PG
ATRS

PEAK6 Group’s Antares Pharma, Inc. ATRS Stock Holding History

PEAK6 Group’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-10,726
Closed -$18K – 5469
2015
Q3 		$18K Buy
+10,726
New +$21K ﹤0.01% 4894
2015
Q1 		– Sell
-15,834
Closed -$41K – 5401
2014
Q4 		$41K Sell
15,834
-1,706
-10% -$3.83K ﹤0.01% 4202
2014
Q3 		$32K Buy
17,540
+4,934
+39% +$10.8K ﹤0.01% 4283
2014
Q2 		$34K Sell
12,606
-1,762
-12% -$5.3K ﹤0.01% 4190
2014
Q1 		$50K Buy
+14,368
New +$63.7K ﹤0.01% 4299
2013
Q4 		– Sell
-81,410
Closed -$165K – 5626
2013
Q3 		$165K Buy
81,410
+42,510
+109% +$186K ﹤0.01% 3825
2013
Q2 		$162 Buy
+38,900
New +$150K ﹤0.01% 3802

Other funds holding ATRS

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PEAK6 Group's ATRS Position: Q4 2015 in Review

PEAK6 Group sold out of Antares Pharma, Inc. (ATRS) in Q4 2015, closing a stake of 10,726 shares — an estimated $18K sold.

PEAK6 Group first reported a position in ATRS in Q2 2013 and held it in 7 quarters. The position peaked at $165K in Q3 2013. 88 funds tracked by Wall St. Rank hold ATRS as of Q4 2015.

  • PEAK6 Group reported no remaining Antares Pharma, Inc. position as of Q4 2015 after selling out during the quarter.
  • PEAK6 Group sold 10,726 Antares Pharma, Inc. shares in Q4 2015, an estimated $18K.
  • PEAK6 Group first reported a position in Antares Pharma, Inc. in Q2 2013 and held it in 7 quarters.
  • PEAK6 Group's Antares Pharma, Inc. position peaked at $165K in Q3 2013.
  • 88 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q4 2015.

Based on PEAK6 Group's 13F filing for Q4 2015, filed 16 Feb 2016.